0000000000371330

AUTHOR

R. Scalia

showing 5 related works from this author

1543P Gemcitabine in classic Kaposi’s sarcoma: A pilot study

2021

Oncologymedicine.medical_specialtyOncologybusiness.industryInternal medicinemedicineClassic Kaposi's sarcomaHematologybusinessGemcitabinemedicine.drugAnnals of Oncology
researchProduct

502P Impact of different selection approaches for identifying Lynch syndrome-related colorectal cancer patients

2021

Oncologymedicine.medical_specialtyOncologybusiness.industryColorectal cancerInternal medicineMedicineHematologybusinessmedicine.diseaseSelection (genetic algorithm)Lynch syndromeAnnals of Oncology
researchProduct

1535P Exploring the dynamic crosstalk between immune system and genetics in a cohort of 116 completely resected gastrointestinal stromal tumors (GIST…

2021

Crosstalk (biology)Immune systemOncologybusiness.industryCohortmedicineCancer researchGastrointestinal stromal tumors (GISTs)Hematologymedicine.diseasebusinessAnnals of Oncology
researchProduct

Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel …

2021

Background Hereditary breast cancer (BC), ovarian cancer (OC), and pancreatic cancer (PC) are the major BRCA-associated tumours. However, some BRCA1/2-wild-type (wt) patients with a strong personal and/or family history of cancer need a further genetic testing through a multi-gene panel containing other high- and moderate-risk susceptibility genes. Patients and methods Our study was aimed to assess if some BC, OC, or PC patients should be offered multi-gene panel testing, based on well-defined criteria concerning their personal and/or family history of cancer, such as earliness of cancer onset, occurrence of multiple tumours, or presence of at least two or more affected first-degree relativ…

OncologyCancer Researchmedicine.medical_specialtySettore MED/06 - Oncologia MedicaPALB2pancreatic cancerBreast NeoplasmsBreast cancerbreast cancerMUTYHInternal medicinePancreatic cancerMedicineHumansGenetic Predisposition to DiseaseGenetic TestingFamily historyCHEK2Original ResearchGenetic testingOvarian Neoplasmsmedicine.diagnostic_testbusiness.industryBRCA1 ProteinCancermedicine.diseasePancreatic Neoplasmsovarian cancerOncologymulti-gene panel testingFemalegermline pathogenic variantsbusiness
researchProduct

166P Hereditary breast, ovarian and pancreatic cancers: Looking beyond the BRCA1/2 genes

2021

Oncologybusiness.industryCancer researchMedicineHematologybusinessGeneAnnals of Oncology
researchProduct